Meneldor Nieuws – Meneldor

Atriva Therapeutics Announces Changes to Advisory Board

Atriva Therapeutics obtains approval from German authorities for Phase II trial in COVID-19 patients, led by Charité Clinic in Berlin

Initiative BEAT-COV fordert Unterstützung für Entwicklung und Produktion neuer, innovativer COVID-19-Medikamente

Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

Atriva announces closing of € 8.6 million ($ 10.2 million) oversubscribed convertible loan

Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target

Aptamer Group on BBC Look North 17th June 2020

LightOx May 2020

Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study

Therapieansätze gegen das Wuhan-Virus Deutsche Forscher entwickeln Impfstoffe gegen Coronaviren

FOR MORE INFORMATION PLEASE CONTACT US